Lytic Pathway
Lytic Pathway - Related Videos
01:30
Lytic Cycle of Bacteriophages
0 Views •
2019
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
11:28
Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
0 Views •
Cited by 2 •
2011
We describe a protocol to identify key roles of host signaling molecules in lytic replication of a model herpesvirus, gamma herpesvirus 68 (γHV68). Utilizing genetically modified mouse strains and embryonic fibroblasts for γHV68 lytic replication, the protocol permits both phenotypic characterization and molecular interrogation of virus-host interactions in viral lytic replication.
02:52
Inducing the Prophage Lytic Replication for Transcriptomic Analysis
0 Views •
2026
Source: Krishnamurthi, R., et al. Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics. J. Vis. Exp. (2024)This video demonstrates the induction of lytic replication in a prophage integrated into the bacterial genome and the capture of gene expression changes through timed sampling for transcriptomic analysis.
07:10
Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
0 Views •
2025
This protocol describes an in vitro system to model de novo lytic infection of Kaposi's sarcoma-associated herpesvirus using BAC16-derived virions. The method enables investigation of early viral replication and dissemination. Infectious virus production is quantified by GFP-based infectious units assays and real-time PCR of encapsidated viral genomes.
01:20
Viral Replication: Lytic Cycle
0 Views •
2025
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
FAQs
C5b initiates an ordered assembly sequence by recruiting C6 and C7, followed by C8 and multiple C9 molecules. This progression produces the membrane attack complex, whose pore-forming structure compromises the target membrane. The coordinated recruitment of these components matters because membrane damage depends on completing the complex rather than on the activity of C5b alone.
The membrane attack complex disrupts membrane integrity by forming a pore-like structure in the target surface. Loss of intact membrane organization can lead to cell lysis in susceptible pathogens. This mechanism gives complement a direct antimicrobial effect, distinct from immune processes that primarily mark microbes for recognition or support their removal by phagocytic cells.
The lytic pathway contributes particularly to the clearance of bacteria, especially Gram-negative organisms. Its effectiveness depends on whether a pathogen is susceptible to membrane attack complex-mediated damage, so complement activation does not produce identical outcomes for every microbe. This selectivity is important when interpreting complement activity in studies of innate antimicrobial defense.
Membrane attack complex formation provides a direct route to pathogen damage, while antibody-mediated recognition and phagocytosis support complementary stages of immune defense. These mechanisms can operate together rather than representing interchangeable processes. Considering them as coordinated activities helps explain how complement contributes both to immediate membrane injury and to broader pathogen clearance.
Regulation is important because complement activity must be understood in relation to both antimicrobial protection and inflammatory injury. Research on the lytic pathway therefore examines not only how membrane attack complexes damage susceptible pathogens, but also how complement activity is controlled. This perspective helps connect pathway behavior with infection outcomes and the consequences of excessive immune-mediated damage.
Studies of the lytic pathway can relate impaired complement function to increased susceptibility to infection. By focusing on the generation of C5b and subsequent membrane attack complex components, investigators can examine where effective terminal complement activity may be compromised. Such work provides context for understanding why defects in complement defenses can affect antimicrobial protection.
Research can connect terminal complement activity with several outcomes, including bacterial clearance, susceptibility to infection, and inflammatory injury. It can also clarify how direct membrane damage works alongside antibody-mediated recognition and phagocytosis. These links make the pathway relevant to immunology studies that investigate innate defense, complement deficiencies, and pathogen-host interactions.
The pathway is relevant to complement-targeted therapy research because its activity has two important dimensions: it can eliminate susceptible pathogens, yet complement-related activity is also associated with inflammatory injury. Understanding the terminal sequence and its regulation helps researchers consider how interventions might influence complement-mediated effects while maintaining the broader context of antimicrobial defense.